{SEMAGLUTIDE: A EMERGING HOPE FOR OBESITY TREATMENT?

The pharmaceutical community is buzzing about semaglutide, a compound initially developed for managing type 2 diabetes. New research indicates that this GLP-1 receptor agonist demonstrates significant efficacy in promoting fat decrease, potentially revolutionizing how we approach obesity . While